Literature DB >> 2426185

Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo.

P M Taylor, B A Askonas.   

Abstract

Influenza nucleoprotein (NP) serves as a target antigen on abortively infected cells for cytotoxic T cells (Tc) cross-reactive for all type A influenza viruses, and it can also prime mice for such Tc. It is important to test the protective ability of NP-specific Tc clones in vivo in a productive influenza infection. In this report, we show that Tc clones of this antigenic specificity protect mice against a lethal influenza infection on transfer to syngeneic recipients, and also that they reduce virus titres in the lungs and trachea of mice challenged with homologous or heterologous type A influenza viruses. Simultaneous injection of IL-2 to maintain the viability of the Tc clones is not essential, but has made the clonal transfer experiments highly reproducible.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426185      PMCID: PMC1453480     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

1.  Cytotoxic T cells to type A influenza virus; viral hemagglutinin induces A-strain specificity while infected cells confer cross-reactive cytotoxicity.

Authors:  H J Zweerink; B A Askonas; D Millican; S A Courtneidge; J J Skehel
Journal:  Eur J Immunol       Date:  1977-09       Impact factor: 5.532

Review 2.  In vivo administration of interleukin-2.

Authors:  M A Cheever; P D Greenberg
Journal:  Contemp Top Mol Immunol       Date:  1985

3.  Abnormal migration of T lymphocyte clones.

Authors:  M O Dailey; C G Fathman; E C Butcher; E Pillemer; I Weissman
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

4.  Diversity in the biological properties of anti-influenza cytotoxic T cell clones.

Authors:  P M Taylor; B A Askonas
Journal:  Eur J Immunol       Date:  1983-09       Impact factor: 5.532

5.  Augmentation of immunity to herpes simplex virus by in vivo administration of interleukin 2.

Authors:  B T Rouse; L S Miller; L Turtinen; R N Moore
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

6.  Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters.

Authors:  G L Smith; B R Murphy; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

7.  Viral recognition by influenza A virus cross-reactive cytotoxic T (Tc) cells: the proportion of Tc cells that recognize nucleoprotein varies between individual mice.

Authors:  P Pala; A R Townsend; B A Askonas
Journal:  Eur J Immunol       Date:  1986-02       Impact factor: 5.532

8.  Outcome of influenza infection: effect of site of initial infection and heterotypic immunity.

Authors:  R A Yetter; S Lehrer; R Ramphal; P A Small
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

9.  Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions.

Authors:  Y L Lin; B A Askonas
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

10.  In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific.

Authors:  A E Lukacher; V L Braciale; T J Braciale
Journal:  J Exp Med       Date:  1984-09-01       Impact factor: 14.307

View more
  108 in total

Review 1.  Cellular and humoral antigenic epitopes in HIV and SIV.

Authors:  D F Nixon; K Broliden; G Ogg; P A Broliden
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

2.  Positive Selection in CD8+ T-Cell Epitopes of Influenza Virus Nucleoprotein Revealed by a Comparative Analysis of Human and Swine Viral Lineages.

Authors:  Heather M Machkovech; Trevor Bedford; Marc A Suchard; Jesse D Bloom
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

3.  Do L3T4+ T cells act as effector cells in protection against influenza virus infection.

Authors:  S Lightman; S Cobbold; H Waldmann; B A Askonas
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

4.  Targeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion protein.

Authors:  T J Goletz; K R Klimpel; N Arora; S H Leppla; J M Keith; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

5.  RNA-mediated transfer of cellular immunity to a synthetic env antigen of the human immunodeficiency virus (HIV-1).

Authors:  G A Passos Júnior; F L de Lucca
Journal:  Mol Cell Biochem       Date:  1991-11-13       Impact factor: 3.396

6.  Development and preclinical evaluation of an alphavirus replicon vaccine for influenza.

Authors:  Bolyn Hubby; Todd Talarico; Maureen Maughan; Elizabeth A Reap; Peter Berglund; Kurt I Kamrud; Laura Copp; Whitney Lewis; Chad Cecil; Pamela Norberg; Jordan Wagner; Aubrey Watson; Sarah Negri; Bruce K Burnett; Andrew Graham; Jonathan F Smith; Jeffrey D Chulay
Journal:  Vaccine       Date:  2007-10-05       Impact factor: 3.641

Review 7.  Heterosubtypic immunity to influenza A virus: where do we stand?

Authors:  Kristie M Grebe; Jonathan W Yewdell; Jack R Bennink
Journal:  Microbes Infect       Date:  2008-07-09       Impact factor: 2.700

8.  Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection.

Authors:  Jun Chen; Yuk Fai Lau; Elaine W Lamirande; Christopher D Paddock; Jeanine H Bartlett; Sherif R Zaki; Kanta Subbarao
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

9.  Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus.

Authors:  A H Cherrie; K Anderson; G W Wertz; P J Openshaw
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Characterization of the cytolytic T-lymphocyte response to a candidate vaccine strain of equine herpesvirus 1 in CBA mice.

Authors:  P M Smith; Y Zhang; S R Jennings; D J O'Callaghan
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.